CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale EVP and CFO sold 1,982 shares at an average $430.87 ($853,993)
- 144 Insider Sale of Securities
- 4 Open-market sale President and CEO sold 1,663 shares at $431.94 ($718,316)
- 144 Insider Sale of Securities
- 4 Open-market sale General Counsel sold 360 shares at $431.94 ($155,498)
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Commercial Officer sold 419 shares at $431.94 ($180,983)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 491 shares at $431.94 ($212,083)
- 144 Insider Sale of Securities
- 4 Grant or award Chief Medical Officer acquired 4,374 shares (grant or award)
- 144 Insider Sale of Securities
- 4 Open-market sale EVP and CFO sold 1,183 shares at $427.21 ($505,389)
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 2,500 shares (option exercise)
- 10-K Report Annual Report
- 8-K Event Results of operations
Page 3 of 62 · 1,224 filings